Effects of the nitric oxide/cGMP system compared with the cAMP system on airway mucus secretion in the rat

被引:10
作者
Bredenbröker, D [1 ]
Dyarmand, D [1 ]
Meingast, U [1 ]
Fehmann, HC [1 ]
Staats, P [1 ]
Von Wichert, P [1 ]
Wagner, U [1 ]
机构
[1] Univ Marburg, Med Poliklin, Dept Internal Med, D-35043 Marburg, Germany
关键词
mucus secretion; nitric oxide (NO); cyclic nucleotide; second messenger; trachea; rat;
D O I
10.1016/S0014-2999(00)00918-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mucus secretion of the airways is under the control of a variety of intracellular second messenger systems. Cyclic nucleotides such as cGMP, coupled to the recently discovered nitric oxide system, and cAMP are of outstanding interest in this respect. The present study used the modified Ussing chamber technique and mucins labelled with (SO4)-S-35 to investigate mucus secretion in the rat trachea to clarify the contribution of these different second messenger systems to the control of mucin secretion. A variety of drugs affecting tither the generation or the breakdown of the respective cyclic nucleotides were used. Neither drugs interfering with nitric oxide synthase nor the phosphodiesterase isoenzyme responsible for cGMP breakdown nor cGMP analogues were able to affect mucus secretion. In contrast, stimulation of adenylate cyclase or inhibition of the respective phosphodiesterase resulted in a potent increase of mucus secretion. In conclusion. we failed to show the involvement of the nitric oxide/cGMP system. whereas the cAMP system seems to be a very efficient regulator of mucus secretion in the rot trachea. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:319 / 325
页数:7
相关论文
共 32 条
[1]   HYPERSECRETION OF MUCIN IN RESPONSE TO INFLAMMATORY MEDIATORS BY GUINEA-PIG TRACHEAL EPITHELIAL-CELLS IN-VITRO IS BLOCKED BY INHIBITION OF NITRIC-OXIDE SYNTHASE [J].
ADLER, KB ;
FISCHER, BM ;
LI, HF ;
CHOE, NH ;
WRIGHT, DT .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 13 (05) :526-530
[2]  
BARANIUK JN, 1990, IMMUNOL ALLERGY CLIN, V10, P383
[3]   NITRIC-OXIDE AND LUNG-DISEASE [J].
BARNES, PJ ;
BELVISI, MG .
THORAX, 1993, 48 (10) :1034-1043
[4]  
BORSON DB, 1988, METHODS BRONCHIAL MU, P303
[5]  
BRDENBROKER D, 1998, EUR RESP J S28, V12, pS180
[6]   MUCOSAL NITRIC-OXIDE MAY TONICALLY SUPPRESS AIRWAYS PLASMA EXUDATION [J].
ERJEFALT, JS ;
ERJEFALT, I ;
SUNDLER, F ;
PERSSON, CGA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (01) :227-232
[7]   Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man - Correlation with neuropeptides [J].
Fischer, A ;
Hoffmann, B .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (01) :209-216
[8]  
FISCHER A, 1992, LAB INVEST, V67, P387
[9]   Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle [J].
Hamad, AM ;
Range, S ;
Holland, E ;
Knox, AJ .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 273 (04) :L807-L813
[10]   IMMUNOCHEMICAL LOCALIZATION OF TYPE-I VIP RECEPTOR AND NK-1-TYPE SUBSTANCE-P RECEPTOR IN RAT LUNG [J].
ICHIKAWA, S ;
SREEDHARAN, SP ;
OWEN, RL ;
GOETZL, EJ .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 268 (04) :L584-L588